Delaware Commission Moves Foward with Medication Rule Updates: THA Racing.Com 3/9/17

By: Tom LaMarra The Delaware Thoroughbred Racing Commission has published several rule modifications, including those related to out-of-competition testing and the Multiple Medication Violation Penalty System, and is poised to adopt them in April following a mandatory 30-day public comment period. The DTRC took the action during its March 8 meeting. The next meeting is

New York Tweaks, Re-Proposes Anti-Stacking Rules for NSAIDS: TDN 2/27/17

By: T.D. Thornton By unanimous voice vote, the New York State Gaming Commission (NYSGC) tweaked and re-proposed a rule Feb. 27 regarding the use of multiple non-steroidal anti-inflammatory drugs (NSAIDs) before horse races in order to eliminate the practice known as “stacking” of those medications while still allowing a second NSAID to be used if

Maryland Commission Streamlines Rule Adoption Process: THA Racing.Com 2/23/17

By: Tom LaMarra The Maryland Racing Commission has developed statutory language that will allow it to adopt updates and changes to model rules—most recently the one on out-of-competition testing—as they are approved by the Association of Racing Commissioners International. The MRC, which held its monthly meeting Feb. 23, falls under the state Department of Labor,

Updated Penalty System Rule Progresses in WV Legislature: THA Racing.Com 2/23/17

By: Tom LaMarra Proposed amendments to Thoroughbred racing rules, including the updated Multiple Medication Violation Penalty System model rule, passed the West Virginia Senate Feb. 17 and await approval by the House of Delegates. West Virginia Racing Commission officials attempted to fast-track the updated MMV rule, which is one of four major components of the

Kentucky Rescinds Dextrophan Positives: Blood-Horse 2/21/17

By: Frank Angst Citing new research that suggests the metabolite of Dextromethorphan, Dextrorphan, can stay in a horse's system at a wider variance of time than previously realized, the Kentucky Horse Racing Commission earlier this year dropped sanctions in three cases where the metabolite was discovered. KHRC equine medical director Mary Scollay offered a presentation

Florida HBPA Pushes for Adoption of Medication Penalty System: THA Racing.Com 2/12/17

By: Tom LaMarra The Florida Horsemen’s Benevolent and Protective Association has reaffirmed its support for uniform medication rules, particularly adoption of the Multiple Medication Violation Penalty System. The FHPBA in a release said it held a meeting Feb. 1 in Orlando, Fla., to offer recommendations on adoption of the Association of Racing Commissioners International model rules

CHRB Faces Another Delay In Third-Party Furosemide Administration: Paulick Report 2/7/17

By: Ray Paulick Efforts by the California Horse Racing Board to begin third-party administration of the anti-bleeder medication furosemide (Salix, formerly Lasix) – initiated in 2012 – suffered another setback last week when the state of California's Office of Administrative Law disapproved an amendment to sections 1433 and 1845 of Title 4 the California Code

ARCI Names Members of New Model Rule Compliance Panel: THA Racing.Com 2/1/17

By: Tom LaMarra Three former racing regulators have been chosen to sit on a panel that will certify jurisdictional compliance with integrity standards each year—the components of the National Uniform Medication Program will be the focal point for 2017. The Association of Racing Commissioners International Feb. 1 named Steve Barham, Bennett Liebman and Allan Monat

With Eye Toward Uniformity, Kentucky Reviews Drug Rules: Blood-Horse 2/1/17

By: Frank Angst After an in-depth review of its racing medication rules relative to the Association of Racing Commissioners International’s recommendations, a Kentucky council is recommending penalty classification changes for a pair of medications. The Kentucky Equine Drug Research Council recommended Feb. 1 that the expectorant ambroxol (Ambril) be moved to a more severe penalty